Nichi-Iko Pharmaceutical Co., Ltd. reported consolidated earnings results for the third quarter ended December 31, 2020. For the quarter, the company reported revenue of ¥138,845 million against ¥142,162 million a year ago. Operating profit was ¥17 million against ¥6,891 million a year ago. Loss was ¥267 million against profit of ¥5,414 million a year ago. Loss per basic and diluted share was ¥3.38 against earnings of ¥86.56 per basic share and ¥86.21 per diluted share a year ago.